Not to be confused with statins, this new pill is the first of its kind.
Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.
The drug from Merck was OK'd for patients with artery-clogging cholesterol that persists even after taking statins.
Most adults have levels of a dangerous type of cholesterol that are above 100, but this new drug can reduce levels to around 50 ...
The daily medication is expected to be list-priced at $10.50 per pill. Here's what to know about Merck's new cholesterol drug Lipfendra.
Lipfendra, to be taken once a day, is designed to help lower cholesterol levels beyond what statins alone can achieve.
Merck will market Lipfendra, which is a first-of-its-kind pill that can reduce cholesterol in a way that’s previously only ...
The FDA has approved a first-of-its-kind pill that can lower "bad" LDL cholesterol with a daily pill instead of a shot. The Food and Drug Administration (FDA) approved on Thursday a first-of-its-kind ...
The U.S. Food and Drug Administration (FDA) has approved a new cholesterol-lowering pill that could help reduce LDL, or the so-called “bad” cholesterol. Dr. Jeffrey Berman, ...
This is read by an automated voice. Please report any issues or inconsistencies here. WASHINGTON — The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce ...
The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that’s previously only been available with expensive, injectable drugs. The drug ...